Understanding M Proteins and Risk Factors in Multiple Myeloma

This chapter delves into the features of M proteins in multiple myeloma, noting that around 50% of patients exhibit IgG type monoclonal proteins. It also explores risk factors such as family history and racial predisposition, particularly the heightened risk for African Americans, while discussing the implications of cytogenetic abnormalities on risk classification for treatment.